Jeuveau is a prescription injectable treatment designed to temporarily improve the appearance of moderate to severe frown lines between the eyebrows, also known as glabellar lines. It contains a purified form of botulinum toxin type A, which works by blocking nerve signals to the muscles, resulting in reduced muscle activity and smoother skin. Approved by the U.S. Food and Drug Administration (FDA) in 2019, Jeuveau is specifically marketed for aesthetic purposes. The treatment is administered by a qualified healthcare professional and typically takes only a few minutes, with results lasting up to three to four months, depending on individual factors.